Gregory Tasian | CHOP Research Institute

In This Section

Gregory Tasian, MD, MSCE

Associate Professor of Surgery and Epidemiology (with tenure)

Dr. Tasian and his research team use an epidemiologic framework, including randomized trials and multi-institutional observational studies, to examine the etiology of kidney stone disease and the comparative effectiveness of surgical interventions. He also employs machine learning of complex data to improve diagnosis, risk stratification, and prediction of treatment response for children and adults with benign urologic disease.

AddtoAny

Bio

The long-term goal of Dr. Tasian's clinical and research programs is to improve the lives of children with nephrolithiasis and congenital urologic disease. His research group uses a combination of large data analytics, behavioral economics, nutritional profiling, and human biospecimen analysis to discover determinants of kidney stone disease with the goal of translating this knowledge into new treatments for kidney stone prevention.

Active projects include examination of metabolic pathways in the gut-kidney axis that could be targets for novel therapeutics to prevent kidney stones. Specifically, Dr. Tasian is investigating the impact of diet and antibiotic exposure on the gut microbiome and metabolites in the intestinal and urinary tract and their contribution to calcium kidney stones in children and adults. He is also performing prospective cohort studies to compare stone clearance and patients’ experiences after alternative surgical interventions for kidney stones. He also applies machine learning to improve understanding of the pathophysiology, diagnosis, risk stratification, and prediction of treatment responses of benign urological disease among children.

Dr. Tasian and his team have made the following discoveries:

Characterized the rapid increase in kidney stone disease among children, adolescents, and young adult women.
Defined the precise relationship between daily temperatures and kidney stone presentation, which has important implications for the impact of climate change on human health.
Recently published the first evidence that oral antibiotics are associated with an increased risk of kidney stones. The risk was greatest for those exposed at younger ages, which could help explain the rapid increase in the incidence of nephrolithiasis among children.
Found that lower renal parenchymal area was associated with an increased risk of end-stage renal disease in boys with posterior urethral valves. Collaborations with Yong Fan at the University of Pennsylvania determined that machine learning of ultrasound images accurately identified children with congenital urologic disease.

Education and Training

BA, Trinity University (Biology and English), 2000

MSc, University of Oxford (Neuroscience), 2004

MD, Baylor College of Medicine, 2005

Fellowship, Children's Hospital of Philadelphia, 2013

MSCE, University of Pennsylvania (Clinical Epidemiology), 2014

Titles and Academic Titles

Attending Urologist

Associate Professor of Surgery and Epidemiology (with tenure)

Director, Pediatric KIDney Stone (PKIDS) Care Improvement Network

Core Faculty, CHOP PolicyLab

Core Faculty, CHOP Center for Pediatric Clinical Effectiveness

Professional Memberships

American Urological Association, 2007-

Society of Pediatric Urology, 2011-

Pediatric National Surgery Quality Improvement Program, 2014-

American College of Surgeons, 2014-

American Medical Association, 2014-

Society of University Urologists, 2014-

Professional Awards

Outstanding Patient Oriented Research Presentation; 22nd annual CHOP Research Poster Day, 2012, 2014

CPCE Pilot Grant Award, 2013

Best Poster Award; International Pediatric Nephrology Association, 2013

American Society for Clinical Investigation Young Physician-Scientist Award, 2016

Election to Research on Calculous Kinetics (ROCK) Society, 2017

Third place, American Urological Association Young Investigator Award, 2017

Publication Highlights

Pubmed:

Gregory Tasian, MD, MSCE

Yin S, Peng Q, Li H, Zhang Z, You X, Fischer K, Furth SL, Fan Y, Tasian G. Multi-instance deep learning of ultrasound imaging data for pattern classification of congenital abnormalities of the kidney and urinary tract in children. Urology. 2020 Aug; 142:183-189. PMID: 32445770

Rubin D, Huang J, Fisher BT, Gasparrini A, Tam V, Song L, Wang X, Kaufman J, Fitzpatrick K, Jain A, Griffis H, Crammer K, Morris J, Tasian GE. Association of Social Distancing, Population Density, and Temperature With the Instantaneous Reproduction Number of SARS-CoV-2 in Counties Across the United States. JAMA Netw Open. 2020 Jul; 3(7):e2016099. DOI:10.1001/jamanetworkopen.2020.16099. PMID: 32701162

Denburg MR, Koepsell KG, Lee JJ, Gerber J, Bittinger K, Tasian GE. Perturbations of the Gut Microbiome and Metabolome in Children with Calcium Oxalate Kidney Stone Disease. J Am Soc Neph. 2020 May; (Epub). DOI: 10.1681/ASN.2019101131. PMID: 32381601

Tasian GE, Jemielita T, Goldfarb DS, Copelovitch L, Gerber J, Wu Q, Denburg MR. Oral Antibiotic Exposure and Kidney Stone Disease. J Am Soc Nephrol. 2018 Jun; 29(6):1731-1740. PMCID: PMC6054354. PMID: 29748329

Tasian GE, Ross ME, Song L, Sas DJ, Keren R, Denburg MR, Chu DI, Copelovitch L, Saigal CS, Furth SL. Annual Incidence of Nephrolithiasis among Children and Adults in South Carolina from 1997 to 2012. Clin J Am Soc Nephrol. 2016 Mar; 11(3):488-96. PMCID: PMC4791823. PMID: 26769765

Active Grants/Contracts

Active

Harnessing Behavior to Decrease Urinary Stone Disease Morbidity

National Institute of Diabetes and Digestive and Kidney Diseases
2016-2021
Goal: To apply behavioral theories to increase adherence to water intake to decrease stone recurrence among adolescents and adults. The project will also examine mechanisms of ureteral stent symptoms after ureteroscopy and establish a biorepository to support future research on urinary stone disease.
Co-PI: Gregory Tasian, MD

Anatomic Biomarkers of Chronic Kidney Disease Progression Among Children

National Institute of Diabetes and Digestive and Kidney Diseases
2019-2021
Goal: To identify and validate biomarkers of chronic kidney disease progression among children with congenital abnormalities of the kidney and urinary tract using machine learning and ultrasound.
Co-PI: Gregory Tasian, MD

Evaluation of the Gut-Kidney Axis in Kidney Stone Disease

National Institute of Diabetes and Digestive and Kidney Diseases
2019-2023
Goal: To determine how diet and antibiotics contribute to nephrolithiasis by perturbing the gut-kidney axis through alterations of the gut microbiome.
PI: Gregory Tasian, MD

Comparative Effectiveness of Pediatric Kidney Stone Surgery

Patient-Centered Outcomes Research Institute
2020-2022
Goal: To compare stone clearance and lived experiences for ureteroscopy, shockwave lithotripsy, and percutaneous nephrolithotomy for pediatric patients with kidney stones.
PI: Gregory Tasian, MD

Center for Machine Learning in Urology

National Institute of Diabetes and Digestive and Kidney Diseases
2021-2021
Goal: To apply cutting-edge approaches in machine learning to analyze complex imaging data for individuals with kidney stone disease. The Center’s strategic vision of using machine learning to generate knowledge that improves diagnosis, risk stratification strategies, and prediction of outcomes among children and adults will be augmented through the implementation of the Educational Enrichment Program.
PI: Gregory Tasian, MD

PENDING

Machine Learning to Predict Outcomes for Children with Urologic Disease

Pennsylvania Department of Health
2020-2024
Goal: To apply machine learning to videourodynamics data to classify, at the point of care, children with spina bifida at greatest risk for chronic kidney disease and thus identify children most likely to benefit from early treatment and spare those who are unlikely to benefit from treatment-related harms.
PI: Gregory Tasian, MD